IDEXX Laboratories (IDXX) Competitors

IDEXX Laboratories (NASDAQ:IDXX) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership, community ranking and earnings.

Does the media favor IDXX or ALC?

In the previous week, Alcon had 1 more articles in the media than IDEXX Laboratories. MarketBeat recorded 14 mentions for Alcon and 13 mentions for IDEXX Laboratories. Alcon's average media sentiment score of 0.75 beat IDEXX Laboratories' score of 0.65 indicating that Alcon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Alcon	3 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better valuation and earnings, IDXX or ALC?

Alcon has higher revenue and earnings than IDEXX Laboratories. Alcon is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$3.66B	12.20	$845.04M	$10.33	52.37
Alcon	$9.46B	4.64	$974M	$2.11	42.20

Do analysts rate IDXX or ALC?

IDEXX Laboratories currently has a consensus price target of $580.38, indicating a potential upside of 7.29%. Alcon has a consensus price target of $94.71, indicating a potential upside of 6.35%. Given IDEXX Laboratories' higher possible upside, equities research analysts clearly believe IDEXX Laboratories is more favorable than Alcon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
Alcon	2 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.67

Is IDXX or ALC more profitable?

IDEXX Laboratories has a net margin of 23.26% compared to Alcon's net margin of 10.96%. IDEXX Laboratories' return on equity of 63.66% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	23.26%	63.66%	27.57%
Alcon	10.96%	6.92%	4.76%

Do institutionals & insiders have more ownership in IDXX or ALC?

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 53.9% of Alcon shares are owned by institutional investors. 2.2% of IDEXX Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Which has more volatility and risk, IDXX or ALC?

IDEXX Laboratories has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, Alcon has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.

Does the MarketBeat Community believe in IDXX or ALC?

IDEXX Laboratories received 347 more outperform votes than Alcon when rated by MarketBeat users. Likewise, 72.65% of users gave IDEXX Laboratories an outperform vote while only 61.72% of users gave Alcon an outperform vote.

Company	Underperform	Outperform
IDEXX Laboratories	Outperform Votes 526 72.65%	Underperform Votes 198 27.35%
Alcon	Outperform Votes 179 61.72%	Underperform Votes 111 38.28%

Summary

IDEXX Laboratories beats Alcon on 12 of the 17 factors compared between the two stocks.